Sales decline 35.23% to Rs 10.68 crore
Net Loss of Bafna Pharmaceuticals reported to Rs 2.77 crore in the quarter ended September 2017 as against net loss of Rs 3.75 crore during the previous quarter ended September 2016. Sales declined 35.23% to Rs 10.68 crore in the quarter ended September 2017 as against Rs 16.49 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales10.6816.49 -35 OPM %2.621.21 -PBDT-1.80-2.78 35 PBT-2.76-3.80 27 NP-2.77-3.75 26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
